Literature DB >> 17455200

Characterization of cecal gene expression in a differentially susceptible mouse model of bacterial-induced inflammatory bowel disease.

Matthew H Myles1, Brian K Dieckgraefe, Jennifer M Criley, Craig L Franklin.   

Abstract

BACKGROUND: A/JCr mice develop typhlitis in response to Helicobacter hepaticus infection, whereas C57BL/6 mice coexist with this bacterium in a "commensal" relationship and do not develop disease even during prolonged colonization.
METHODS: To determine mechanisms that control this balance between responsiveness and nonresponsiveness, the mucosal response of A/JCr and C57BL/6 mice to acute H. hepaticus colonization was evaluated using genome-wide profiling. Transcription levels for a subset of gene discoveries were then evaluated longitudinally by semiquantitative real-time reverse-transcriptase polymerase chain reaction (RT-PCR) to identify changes in gene expression that occur during progression from the acute to chronic phase of colonization. To determine whether chronic mucosal inflammation in A/JCr mice was mediated through a Th1 mechanism, as was inferred from the gene expression data, mice with typhlitis were treated with neutralizing antibody targeting IL-12/23p40 or IFN-gamma and the response to treatment was determined by cecal lesion severity and transcription of disease-related genes.
RESULTS: A/JCr mice had a biphasic expression of proinflammatory genes that corresponded with the acute and chronic phases of disease. In contrast, C57BL/6 mice exhibited a less robust acute transcriptional response that waned by day 30 postinoculation. Sustained upregulation of proinflammatory signals and responsiveness to anti-IL-12/23p40 and anti-IFN-gamma antibody suggests that inflammation in A/JCr mice was mediated through a Th1 mechanism. Prolonged upregulation of SOCS3 during the acute response to colonization suggests that C57BL/6 mice maintain mucosal homeostasis, at least in part by attenuating responsiveness to cytokine signaling.
CONCLUSIONS: Collectively, these findings provide a foundation for understanding the immunological mechanisms that confer resistance or susceptibility to H. hepaticus-induced typhlitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17455200     DOI: 10.1002/ibd.20138

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  20 in total

Review 1.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

2.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

3.  Quantitative trait loci in a bacterially induced model of inflammatory bowel disease.

Authors:  Andrew E Hillhouse; Matthew H Myles; Jeremy F Taylor; Elizabeth C Bryda; Craig L Franklin
Journal:  Mamm Genome       Date:  2011-06-30       Impact factor: 2.957

4.  LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.

Authors:  Wioletta K Glowacka; Philipp Alberts; Rika Ouchida; Ji-Yang Wang; Daniela Rotin
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

5.  Helicobacter Infection Significantly Alters Pregnancy Success in Laboratory Mice.

Authors:  Tara C Bracken; Caitlin A Cooper; Zil Ali; Ha Truong; Julie M Moore
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-05-01       Impact factor: 1.232

6.  Noninvasive detection of inflammation-associated colon cancer in a mouse model.

Authors:  Aaron C Ericsson; Matthew Myles; Wade Davis; Lixin Ma; Michael Lewis; Lillian Maggio-Price; Craig Franklin
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

7.  Evaluation of a commercial colorimetric fecal dipstick assay for the detection of Helicobacter hepaticus infections in laboratory mice.

Authors:  Julie E Freebersyser; Michael T Drake; Lela K Riley; Matthew H Myles; Robert S Livingston
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

Review 8.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer.

Authors:  Stacey Meeker; Audrey Seamons; Jisun Paik; Piper M Treuting; Thea Brabb; William M Grady; Lillian Maggio-Price
Journal:  Cancer Res       Date:  2014-06-17       Impact factor: 12.701

10.  Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in Macrophages.

Authors:  Avijit Ray; Sreemanti Basu; Raad Z Gharaibeh; Lydia C Cook; Ranjit Kumar; Elliot J Lefkowitz; Catherine R Walker; Casey D Morrow; Craig L Franklin; Terrence L Geiger; Nita H Salzman; Anthony Fodor; Bonnie N Dittel
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.